West Pharmaceutical Services Inc (WST)
Operating profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 676,000 | 644,800 | 653,700 | 699,600 | 734,000 | 788,300 | 783,500 | 766,400 | 752,300 | 684,400 | 602,200 | 494,500 | 406,900 | 368,900 | 337,000 | 313,900 | 296,600 | 284,300 | 277,800 | 257,600 |
| Revenue (ttm) | US$ in thousands | 2,931,600 | 2,918,300 | 2,862,000 | 2,884,600 | 2,888,000 | 2,911,600 | 2,929,000 | 2,882,500 | 2,833,200 | 2,681,100 | 2,521,700 | 2,320,600 | 2,141,400 | 2,030,200 | 1,941,400 | 1,887,900 | 1,839,900 | 1,791,800 | 1,767,400 | 1,745,200 |
| Operating profit margin | 23.06% | 22.10% | 22.84% | 24.25% | 25.42% | 27.07% | 26.75% | 26.59% | 26.55% | 25.53% | 23.88% | 21.31% | 19.00% | 18.17% | 17.36% | 16.63% | 16.12% | 15.87% | 15.72% | 14.76% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $676,000K ÷ $2,931,600K
= 23.06%
West Pharmaceutical Services, Inc.'s operating profit margin has displayed slight fluctuations over the past eight quarters. The margin has ranged from a high of 27.13% in Q3 2022 to a low of 23.85% in Q3 2023. Generally speaking, the company has maintained strong operating profitability, consistently achieving margins above 23% in each quarter. However, there has been a downward trend in recent quarters, with margins decreasing from 27.13% in Q3 2022 to 23.85% in Q3 2023. This decrease could indicate potential challenges in managing operating expenses or maintaining revenue growth. It would be important for stakeholders to monitor future financial performance to assess if this trend continues or if margins improve in the upcoming quarters.
Peer comparison
Dec 31, 2023